NCT00005010View on ClinicalTrials.gov

Prevention of Kidney Transplant Rejection

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Study Completion Date

March 31, 2004

Conditions

End-Stage Renal DiseaseChronic Allograft Nephropathy

Interventions

DRUG

Irbesartan

DRUG

Pravastatin

Trial Locations (1)

20850

Ilene Blechman-Krom, Rockville

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH